Login / Signup
Oscar Ardenfors
ORCID
Publication Activity (10 Years)
Years Active: 2022-2024
Publications (10 Years): 4
Top Topics
Combination Therapy
Bone Marrow
Positron Emission Tomography
Contrast Enhanced
Top Venues
EJNMMI research
EJNMMI physics
Thyroid research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Märta Persson
,
Cecilia Hindorf
,
Oscar Ardenfors
,
Martin Larsson
,
Joachim N Nilsson
Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy.
EJNMMI research
14 (1) (2024)
Märta Persson
,
Cecilia Hindorf
,
Oscar Ardenfors
,
Martin Larsson
,
Joachim N Nilsson
Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy.
EJNMMI research
14 (1) (2024)
Joachim N Nilsson
,
Rebecca Elovsson
,
Daniel Thor
,
Jan Calissendorff
,
Oscar Ardenfors
Radioiodine treatment outcome by dosimetric parameters and renal function in hyperthyroidism.
Thyroid research
15 (1) (2022)
Oscar Ardenfors
,
Joachim N Nilsson
,
Daniel Thor
,
Cecilia Hindorf
Simplified dosimetry for kidneys and tumors in 177 Lu-labeled peptide receptor radionuclide therapy.
EJNMMI physics
9 (1) (2022)